期刊文献+

阿齐沙坦片溶出度方法学研究 被引量:1

Dissolution Method Study of Azilsartan Tablets
下载PDF
导出
摘要 建立阿齐沙坦片的溶出度测定方法,并进行方法学研究。采用p H6.8磷酸盐缓冲液900m L为溶出介质,转速为50r/min,取样时间为45min,紫外-可见分光光度法检测,检测波长为245nm。阿齐沙坦在1.035 6~11.3913μg/m L浓度范围内(r=0.999 7)呈良好的线性关系,平均回收率为99.3%,RSD为1.0%.本法能够用于测定阿齐沙坦片的溶出度,操作简便,准确可靠。 To establish a dissolution method for Azilsartan Tablets.Dissolution medium is PH6.8 pHospHate buffer 900ml,speed is 50r/min,sampling time is 45 minutes and by UV-Visible spectropHotometry detecting and detection wavelength is 245nm.Azilsartan within 1.035 6~11.391 3μg/mlConcentration range(r=0.999 7)showed a good linear relationship,and the averageRecovery rate was 99.3%,RSD was 1.0%.The method is simple,accurate and reliable,which can be used for detecting the dissolution of Azilsartan Tablets.
作者 朱亚东 黄柳 Zhu Ya-dong;Huang Liu
出处 《化工设计通讯》 CAS 2018年第8期197-197,199,共2页 Chemical Engineering Design Communications
关键词 阿齐沙坦片 溶出度 紫外-可见分光光度法 azilsartan Tablets dissolution UV-visible spectropHotometry
  • 相关文献

参考文献2

二级参考文献17

  • 1Ku MS, Dulin W. A biopharmaceutical classification based Right-First-Time formulation approach to reduce human phar- macokinetic variability and project cycle time from First In-Hu- man to clinical Proof-Of Concept [J]. Pharma Dev Technol, 2010, 17(3): 285-302.
  • 2Takagi T, Ramachandran C, Amidon GL, et al. A provisional biopharmaceutical classification of the top 200 oral drug prod ucts in the United States, Great Britain, Spain, and Japan[J]. Mol Pharm, 2006, 3(6): 631-643.
  • 3Amidon GL, Lennernas H, Shah VP, etal. A theoretical ba- sis for a biopharmaeeutie drug classi? cation: the correlation of in vitro drug product dissolution and in vivo bioavailability[J]. Pharm Res, 1995, 12(3):413-420.
  • 4Volpe D A. Variability in Caeo-2 and MI)CK cell based intesti nal permeability assays[J]. J Pharm Sci, 2008, 97 (2) : 712-725.
  • 5Cook J, Addicks W, Wu YH. Application of the biopharma- ceutical classification system in clinical drug development- an industrial view[J]. AAPS J,2008, 10(2) : 3116-310.
  • 6Jung MS, Kim JS, Kim MS, et al. Bioavailability of indom ethacin-saccharin cocrystals[J]. J Pharm Pharmacol, 2010, 62 (11): 1560-1568.
  • 7Bak A, Gore A, Yanez E, et al. The co-crystal approach to improve the exposure of a water-insoluble compound~ AMG 517 sorbic acid co-crystal characterization and pharmacokinetics [J]. J Pharm Sci, 2008, 97(9) : 3942-3956.
  • 8Shegokar R, Muller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble ac- tives[J]. Int J Pharm, 2010, 399(1-2): 129-139.
  • 9Sylvestre JP, Tang MC, Furtos A, et al. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu[J]. J Controlled Rel, 2011, 149(3) : 273-280.
  • 10Vasconeelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs[J]. Drug Dis Today 2007, 12(23-24): 1068-1075.

共引文献49

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部